Shares of First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT – Get Free Report) were down 1.8% on Tuesday . The stock traded as low as $167.22 and last traded at $168.46. Approximately 15,170 shares changed hands during mid-day trading, a decline of 41% from the average daily volume of 25,921 shares. The stock had previously closed at $171.49.
First Trust NYSE Arca Biotechnology Index Fund Stock Performance
The business has a 50 day moving average price of $175.04 and a 200-day moving average price of $172.09. The company has a market capitalization of $1.11 billion, a price-to-earnings ratio of 24.18 and a beta of 0.70.
Hedge Funds Weigh In On First Trust NYSE Arca Biotechnology Index Fund
Several institutional investors have recently added to or reduced their stakes in the business. Sherman Asset Management Inc. bought a new stake in shares of First Trust NYSE Arca Biotechnology Index Fund in the 4th quarter valued at $50,000. Ameriflex Group Inc. acquired a new stake in First Trust NYSE Arca Biotechnology Index Fund in the fourth quarter worth $52,000. Aptus Capital Advisors LLC grew its holdings in First Trust NYSE Arca Biotechnology Index Fund by 17,250.0% in the fourth quarter. Aptus Capital Advisors LLC now owns 347 shares of the company’s stock worth $58,000 after purchasing an additional 345 shares during the period. Principal Securities Inc. increased its stake in First Trust NYSE Arca Biotechnology Index Fund by 17.0% in the fourth quarter. Principal Securities Inc. now owns 730 shares of the company’s stock valued at $121,000 after purchasing an additional 106 shares in the last quarter. Finally, Park Square Financial Group LLC acquired a new position in shares of First Trust NYSE Arca Biotechnology Index Fund during the fourth quarter valued at about $123,000.
First Trust NYSE Arca Biotechnology Index Fund Company Profile
The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.
Featured Articles
- Five stocks we like better than First Trust NYSE Arca Biotechnology Index Fund
- Find and Profitably Trade Stocks at 52-Week Lows
- NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
- Consumer Staples Stocks, Explained
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- The Basics of Support and Resistance
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
Receive News & Ratings for First Trust NYSE Arca Biotechnology Index Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust NYSE Arca Biotechnology Index Fund and related companies with MarketBeat.com's FREE daily email newsletter.
